Literature DB >> 8684835

The role of MHC- and non-MHC-associated genes in determining the human immune response to malaria antigens.

E M Riley1.   

Abstract

Individual susceptibility to malaria infection, disease and death is influenced by host genotype, parasite virulence and a number of environmental factors including malaria-specific immunity. Immune responses are themselves determined by a combination of host genes and environmental effects. The extent to which host genotype limits the spectrum of possible immune responses may influence the outcome of infection and has consequences for vaccine design. Associations have been observed between human major histocompatibility complex (MHC) genotype and susceptibility to severe malaria, but no similar associations have been observed for mild malarial disease or for specific antibody responses to defined malaria antigens. Epidemiological studies have shown that, in practice, neither T helper cell nor antibody responses to malaria parasite are limited by host MHC genotype, but have revealed that genes lying outside the MHC may influence T cell proliferative responses. These genes have yet to be identified, but possible candidates include T cell receptor (TcR) genes, and genes involved in TcR gene rearrangements. More importantly, perhaps, longitudinal epidemiological studies have shown that the anti-malarial antibody repertoire is selective and becomes fixed in malaria-immune individuals, but is independent of host genotype. These findings suggest that the antibody repertoire may be determined, at least in part, by stochastic events. The first of these is the generation of the T and B cell repertoire, which results from random gene recombinations and somatic mutation and is thus partially independent of germline genes. Secondly, of the profusion of immunogenic peptides which are processed and presented by antigen presenting cells, a few will, by chance, interact with T and B cell surface antigen receptors of particularly high affinity. These T and B cell clones will be selected, will expand and may come to dominate the immune response, preventing the recognition of variant epitopes presented by subsequent infections-a process known as original antigenic sin or clonal imprinting. The immune response of an individual thus reflects the balance between genetic and stochastic effects. This may have important consequences for subunit vaccine development.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8684835

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  8 in total

1.  Malaria infection induces rapid elevation of the soluble Fas ligand level in serum and subsequent T lymphocytopenia: possible factors responsible for the differences in susceptibility of two species of Macaca monkeys to Plasmodium coatneyi infection.

Authors:  J Matsumoto; S Kawai; K Terao; M Kirinoki; Y Yasutomi; M Aikawa; H Matsuda
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

2.  Antibodies to the N-terminal block 2 of Plasmodium falciparum merozoite surface protein 1 are associated with protection against clinical malaria.

Authors:  David R Cavanagh; Daniel Dodoo; Lars Hviid; Jørgen A L Kurtzhals; Thor G Theander; Bartholomew D Akanmori; Spencer Polley; David J Conway; Kojo Koram; Jana S McBride
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

3.  Analysis of immunological nonresponsiveness to the 19-kilodalton fragment of merozoite surface Protein 1 of Plasmodium yoelii: rescue by chemical conjugation to diphtheria toxoid (DT) and enhancement of immunogenicity by prior DT vaccination.

Authors:  Danielle I Stanisic; Laura B Martin; Xue Q Liu; David Jackson; Juan Cooper; Michael F Good
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

4.  The evolution of primate malaria parasites based on the gene encoding cytochrome b from the linear mitochondrial genome.

Authors:  A A Escalante; D E Freeland; W E Collins; A A Lal
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

5.  Reduced CD3/TCR complex expression leads to immunosuppression during Plasmodium falciparum malaria.

Authors:  Yvonne Kalmbach; Angelica B W Boldt; Benjamin Mordmüller; Maryvonne Kombila; Martin P Grobusch; Peter G Kremsner; Jürgen F J Kun
Journal:  Parasitol Res       Date:  2008-10-31       Impact factor: 2.289

6.  Genetic diversity and antigenic polymorphism in Plasmodium falciparum: extensive serological cross-reactivity between allelic variants of merozoite surface protein 2.

Authors:  Simon Franks; Luke Baton; Kevin Tetteh; Eric Tongren; David Dewin; Bartholomew D Akanmori; Kojo A Koram; Lisa Ranford-Cartwright; Eleanor M Riley
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

7.  Intermittent preventive treatment with sulfadoxine-pyrimethamine does not modify plasma cytokines and chemokines or intracellular cytokine responses to Plasmodium falciparum in Mozambican children.

Authors:  Diana Quelhas; Laura Puyol; Llorenç Quintó; Tacilta Nhampossa; Elisa Serra-Casas; Eusébio Macete; Pedro Aide; Sergi Sanz; John J Aponte; Denise L Doolan; Pedro L Alonso; Clara Menéndez; Carlota Dobaño
Journal:  BMC Immunol       Date:  2012-01-26       Impact factor: 3.615

8.  VaccImm: simulating peptide vaccination in cancer therapy.

Authors:  Joachim von Eichborn; Anna Lena Woelke; Filippo Castiglione; Robert Preissner
Journal:  BMC Bioinformatics       Date:  2013-04-15       Impact factor: 3.169

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.